Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
John Paul Shen, Rohith Srivas, Andrew Gross, Jianfeng Li, Eric J. Jaehnig, Su Ming Sun, Ana Bojorquez-Gomez, Katherine Licon, Vignesh Sivaganesh, Jia L. Xu, Kristin Klepper, Huwate Yeerna, Daniel Pekin, Chu Ping Qiu, Haico van Attikum, Robert W. Sobol, Trey Ideker
Published Sep 30, 2015 · Vol. 6, No. 34 · pp. 35755-35769
Ila Datar, Xiaoliang Qiu, Hong Zhi Ma, Miranda Yeung, Shweta Aras, Ivana de la Serna, Fahd Al-Mulla, Jean Paul Thiery, Robert Trumbly, Xuan Fan, Hongjuan Cui, Kam C. Yeung
Published Aug 13, 2015 · Vol. 6, No. 36 · pp. 39050-39061